This report aims to provide a comprehensive presentation of the global market for Neisseria meningitidis Infections Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neisseria meningitidis Infections Drug. This report contains market size and forecasts of Neisseria meningitidis Infections Drug in global, including the following market information:
Global Neisseria meningitidis Infections Drug Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Neisseria meningitidis Infections Drug Market Sales, 2018-2023, 2024-2032, (K Pcs)
Global top five Neisseria meningitidis Infections Drug companies in 2022 (%)
The global Neisseria meningitidis Infections Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
MGBBP-3 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Neisseria meningitidis Infections Drug include Beijing Minhai Biotechnology Co Ltd, Biological E Ltd, China National Pharmaceutical Group Corp, GlaxoSmithKline Plc, Griffith University, ImmunoBiology Ltd, JN-International Medical Corp, MGB Biopharma Ltd and Panacea Biotec Ltd, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Neisseria meningitidis Infections Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neisseria meningitidis Infections Drug Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Neisseria meningitidis Infections Drug Market Segment Percentages, by Type, 2022 (%)
MGBBP-3
NCL-195
TP-10
Others
Global Neisseria meningitidis Infections Drug Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Neisseria meningitidis Infections Drug Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Neisseria meningitidis Infections Drug Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Neisseria meningitidis Infections Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neisseria meningitidis Infections Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Neisseria meningitidis Infections Drug revenues share in global market, 2022 (%)
Key companies Neisseria meningitidis Infections Drug sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Neisseria meningitidis Infections Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Beijing Minhai Biotechnology Co Ltd
Biological E Ltd
China National Pharmaceutical Group Corp
GlaxoSmithKline Plc
Griffith University
ImmunoBiology Ltd
JN-International Medical Corp
MGB Biopharma Ltd
Panacea Biotec Ltd
Pfizer Inc
Sanofi Pasteur SA
Serum Institute of India Ltd
Wellstat Vaccines LLC
Outline of Major Chapters:
Chapter 1: Introduces the definition of Neisseria meningitidis Infections Drug, market overview.
Chapter 2: Global Neisseria meningitidis Infections Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Neisseria meningitidis Infections Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Neisseria meningitidis Infections Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Neisseria meningitidis Infections Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Neisseria meningitidis Infections Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neisseria meningitidis Infections Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neisseria meningitidis Infections Drug Overall Market Size
2.1 Global Neisseria meningitidis Infections Drug Market Size: 2022 VS 2030
2.2 Global Neisseria meningitidis Infections Drug Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Neisseria meningitidis Infections Drug Sales: 2018-2030
3 Company Landscape
3.1 Top Neisseria meningitidis Infections Drug Players in Global Market
3.2 Top Global Neisseria meningitidis Infections Drug Companies Ranked by Revenue
3.3 Global Neisseria meningitidis Infections Drug Revenue by Companies
3.4 Global Neisseria meningitidis Infections Drug Sales by Companies
3.5 Global Neisseria meningitidis Infections Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Neisseria meningitidis Infections Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Neisseria meningitidis Infections Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Neisseria meningitidis Infections Drug Players in Global Market
3.8.1 List of Global Tier 1 Neisseria meningitidis Infections Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Neisseria meningitidis Infections Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Neisseria meningitidis Infections Drug Market Size Markets, 2022 & 2030
4.1.2 MGBBP-3
4.1.3 NCL-195
4.1.4 TP-10
4.1.5 Others
4.2 By Type - Global Neisseria meningitidis Infections Drug Revenue & Forecasts
4.2.1 By Type - Global Neisseria meningitidis Infections Drug Revenue, 2018-2023
4.2.2 By Type - Global Neisseria meningitidis Infections Drug Revenue, 2024-2030
4.2.3 By Type - Global Neisseria meningitidis Infections Drug Revenue Market Share, 2018-2030
4.3 By Type - Global Neisseria meningitidis Infections Drug Sales & Forecasts
4.3.1 By Type - Global Neisseria meningitidis Infections Drug Sales, 2018-2023
4.3.2 By Type - Global Neisseria meningitidis Infections Drug Sales, 2024-2030
4.3.3 By Type - Global Neisseria meningitidis Infections Drug Sales Market Share, 2018-2030
4.4 By Type - Global Neisseria meningitidis Infections Drug Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neisseria meningitidis Infections Drug Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Neisseria meningitidis Infections Drug Revenue & Forecasts
5.2.1 By Application - Global Neisseria meningitidis Infections Drug Revenue, 2018-2023
5.2.2 By Application - Global Neisseria meningitidis Infections Drug Revenue, 2024-2030
5.2.3 By Application - Global Neisseria meningitidis Infections Drug Revenue Market Share, 2018-2030
5.3 By Application - Global Neisseria meningitidis Infections Drug Sales & Forecasts
5.3.1 By Application - Global Neisseria meningitidis Infections Drug Sales, 2018-2023
5.3.2 By Application - Global Neisseria meningitidis Infections Drug Sales, 2024-2030
5.3.3 By Application - Global Neisseria meningitidis Infections Drug Sales Market Share, 2018-2030
5.4 By Application - Global Neisseria meningitidis Infections Drug Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Neisseria meningitidis Infections Drug Market Size, 2022 & 2030
6.2 By Region - Global Neisseria meningitidis Infections Drug Revenue & Forecasts
6.2.1 By Region - Global Neisseria meningitidis Infections Drug Revenue, 2018-2023
6.2.2 By Region - Global Neisseria meningitidis Infections Drug Revenue, 2024-2030
6.2.3 By Region - Global Neisseria meningitidis Infections Drug Revenue Market Share, 2018-2030
6.3 By Region - Global Neisseria meningitidis Infections Drug Sales & Forecasts
6.3.1 By Region - Global Neisseria meningitidis Infections Drug Sales, 2018-2023
6.3.2 By Region - Global Neisseria meningitidis Infections Drug Sales, 2024-2030
6.3.3 By Region - Global Neisseria meningitidis Infections Drug Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Neisseria meningitidis Infections Drug Revenue, 2018-2030
6.4.2 By Country - North America Neisseria meningitidis Infections Drug Sales, 2018-2030
6.4.3 US Neisseria meningitidis Infections Drug Market Size, 2018-2030
6.4.4 Canada Neisseria meningitidis Infections Drug Market Size, 2018-2030
6.4.5 Mexico Neisseria meningitidis Infections Drug Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Neisseria meningitidis Infections Drug Revenue, 2018-2030
6.5.2 By Country - Europe Neisseria meningitidis Infections Drug Sales, 2018-2030
6.5.3 Germany Neisseria meningitidis Infections Drug Market Size, 2018-2030
6.5.4 France Neisseria meningitidis Infections Drug Market Size, 2018-2030
6.5.5 U.K. Neisseria meningitidis Infections Drug Market Size, 2018-2030
6.5.6 Italy Neisseria meningitidis Infections Drug Market Size, 2018-2030
6.5.7 Russia Neisseria meningitidis Infections Drug Market Size, 2018-2030
6.5.8 Nordic Countries Neisseria meningitidis Infections Drug Market Size, 2018-2030
6.5.9 Benelux Neisseria meningitidis Infections Drug Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Neisseria meningitidis Infections Drug Revenue, 2018-2030
6.6.2 By Region - Asia Neisseria meningitidis Infections Drug Sales, 2018-2030
6.6.3 China Neisseria meningitidis Infections Drug Market Size, 2018-2030
6.6.4 Japan Neisseria meningitidis Infections Drug Market Size, 2018-2030
6.6.5 South Korea Neisseria meningitidis Infections Drug Market Size, 2018-2030
6.6.6 Southeast Asia Neisseria meningitidis Infections Drug Market Size, 2018-2030
6.6.7 India Neisseria meningitidis Infections Drug Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Neisseria meningitidis Infections Drug Revenue, 2018-2030
6.7.2 By Country - South America Neisseria meningitidis Infections Drug Sales, 2018-2030
6.7.3 Brazil Neisseria meningitidis Infections Drug Market Size, 2018-2030
6.7.4 Argentina Neisseria meningitidis Infections Drug Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Neisseria meningitidis Infections Drug Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Neisseria meningitidis Infections Drug Sales, 2018-2030
6.8.3 Turkey Neisseria meningitidis Infections Drug Market Size, 2018-2030
6.8.4 Israel Neisseria meningitidis Infections Drug Market Size, 2018-2030
6.8.5 Saudi Arabia Neisseria meningitidis Infections Drug Market Size, 2018-2030
6.8.6 UAE Neisseria meningitidis Infections Drug Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Beijing Minhai Biotechnology Co Ltd
7.1.1 Beijing Minhai Biotechnology Co Ltd Company Summary
7.1.2 Beijing Minhai Biotechnology Co Ltd Business Overview
7.1.3 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Major Product Offerings
7.1.4 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales and Revenue in Global (2018-2023)
7.1.5 Beijing Minhai Biotechnology Co Ltd Key News & Latest Developments
7.2 Biological E Ltd
7.2.1 Biological E Ltd Company Summary
7.2.2 Biological E Ltd Business Overview
7.2.3 Biological E Ltd Neisseria meningitidis Infections Drug Major Product Offerings
7.2.4 Biological E Ltd Neisseria meningitidis Infections Drug Sales and Revenue in Global (2018-2023)
7.2.5 Biological E Ltd Key News & Latest Developments
7.3 China National Pharmaceutical Group Corp
7.3.1 China National Pharmaceutical Group Corp Company Summary
7.3.2 China National Pharmaceutical Group Corp Business Overview
7.3.3 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Major Product Offerings
7.3.4 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales and Revenue in Global (2018-2023)
7.3.5 China National Pharmaceutical Group Corp Key News & Latest Developments
7.4 GlaxoSmithKline Plc
7.4.1 GlaxoSmithKline Plc Company Summary
7.4.2 GlaxoSmithKline Plc Business Overview
7.4.3 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Major Product Offerings
7.4.4 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales and Revenue in Global (2018-2023)
7.4.5 GlaxoSmithKline Plc Key News & Latest Developments
7.5 Griffith University
7.5.1 Griffith University Company Summary
7.5.2 Griffith University Business Overview
7.5.3 Griffith University Neisseria meningitidis Infections Drug Major Product Offerings
7.5.4 Griffith University Neisseria meningitidis Infections Drug Sales and Revenue in Global (2018-2023)
7.5.5 Griffith University Key News & Latest Developments
7.6 ImmunoBiology Ltd
7.6.1 ImmunoBiology Ltd Company Summary
7.6.2 ImmunoBiology Ltd Business Overview
7.6.3 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Major Product Offerings
7.6.4 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales and Revenue in Global (2018-2023)
7.6.5 ImmunoBiology Ltd Key News & Latest Developments
7.7 JN-International Medical Corp
7.7.1 JN-International Medical Corp Company Summary
7.7.2 JN-International Medical Corp Business Overview
7.7.3 JN-International Medical Corp Neisseria meningitidis Infections Drug Major Product Offerings
7.7.4 JN-International Medical Corp Neisseria meningitidis Infections Drug Sales and Revenue in Global (2018-2023)
7.7.5 JN-International Medical Corp Key News & Latest Developments
7.8 MGB Biopharma Ltd
7.8.1 MGB Biopharma Ltd Company Summary
7.8.2 MGB Biopharma Ltd Business Overview
7.8.3 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Major Product Offerings
7.8.4 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales and Revenue in Global (2018-2023)
7.8.5 MGB Biopharma Ltd Key News & Latest Developments
7.9 Panacea Biotec Ltd
7.9.1 Panacea Biotec Ltd Company Summary
7.9.2 Panacea Biotec Ltd Business Overview
7.9.3 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Major Product Offerings
7.9.4 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales and Revenue in Global (2018-2023)
7.9.5 Panacea Biotec Ltd Key News & Latest Developments
7.10 Pfizer Inc
7.10.1 Pfizer Inc Company Summary
7.10.2 Pfizer Inc Business Overview
7.10.3 Pfizer Inc Neisseria meningitidis Infections Drug Major Product Offerings
7.10.4 Pfizer Inc Neisseria meningitidis Infections Drug Sales and Revenue in Global (2018-2023)
7.10.5 Pfizer Inc Key News & Latest Developments
7.11 Sanofi Pasteur SA
7.11.1 Sanofi Pasteur SA Company Summary
7.11.2 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Business Overview
7.11.3 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Major Product Offerings
7.11.4 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Sales and Revenue in Global (2018-2023)
7.11.5 Sanofi Pasteur SA Key News & Latest Developments
7.12 Serum Institute of India Ltd
7.12.1 Serum Institute of India Ltd Company Summary
7.12.2 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Business Overview
7.12.3 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Major Product Offerings
7.12.4 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Sales and Revenue in Global (2018-2023)
7.12.5 Serum Institute of India Ltd Key News & Latest Developments
7.13 Wellstat Vaccines LLC
7.13.1 Wellstat Vaccines LLC Company Summary
7.13.2 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Business Overview
7.13.3 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Major Product Offerings
7.13.4 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Sales and Revenue in Global (2018-2023)
7.13.5 Wellstat Vaccines LLC Key News & Latest Developments
8 Global Neisseria meningitidis Infections Drug Production Capacity, Analysis
8.1 Global Neisseria meningitidis Infections Drug Production Capacity, 2018-2030
8.2 Neisseria meningitidis Infections Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Neisseria meningitidis Infections Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Neisseria meningitidis Infections Drug Supply Chain Analysis
10.1 Neisseria meningitidis Infections Drug Industry Value Chain
10.2 Neisseria meningitidis Infections Drug Upstream Market
10.3 Neisseria meningitidis Infections Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Neisseria meningitidis Infections Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Neisseria meningitidis Infections Drug in Global Market
Table 2. Top Neisseria meningitidis Infections Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Neisseria meningitidis Infections Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Neisseria meningitidis Infections Drug Revenue Share by Companies, 2018-2023
Table 5. Global Neisseria meningitidis Infections Drug Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Neisseria meningitidis Infections Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Neisseria meningitidis Infections Drug Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Neisseria meningitidis Infections Drug Product Type
Table 9. List of Global Tier 1 Neisseria meningitidis Infections Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neisseria meningitidis Infections Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Neisseria meningitidis Infections Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Neisseria meningitidis Infections Drug Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Neisseria meningitidis Infections Drug Sales (K Pcs), 2018-2023
Table 15. By Type - Global Neisseria meningitidis Infections Drug Sales (K Pcs), 2024-2030
Table 16. By Application ? Global Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Neisseria meningitidis Infections Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Neisseria meningitidis Infections Drug Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Neisseria meningitidis Infections Drug Sales (K Pcs), 2018-2023
Table 20. By Application - Global Neisseria meningitidis Infections Drug Sales (K Pcs), 2024-2030
Table 21. By Region ? Global Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Neisseria meningitidis Infections Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Neisseria meningitidis Infections Drug Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Neisseria meningitidis Infections Drug Sales (K Pcs), 2018-2023
Table 25. By Region - Global Neisseria meningitidis Infections Drug Sales (K Pcs), 2024-2030
Table 26. By Country - North America Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Neisseria meningitidis Infections Drug Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Neisseria meningitidis Infections Drug Sales, (K Pcs), 2024-2030
Table 30. By Country - Europe Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Neisseria meningitidis Infections Drug Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Neisseria meningitidis Infections Drug Sales, (K Pcs), 2024-2030
Table 34. By Region - Asia Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Neisseria meningitidis Infections Drug Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Neisseria meningitidis Infections Drug Sales, (K Pcs), 2024-2030
Table 38. By Country - South America Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Neisseria meningitidis Infections Drug Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Neisseria meningitidis Infections Drug Sales, (K Pcs), 2024-2030
Table 42. By Country - Middle East & Africa Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Neisseria meningitidis Infections Drug Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Neisseria meningitidis Infections Drug Sales, (K Pcs), 2024-2030
Table 46. Beijing Minhai Biotechnology Co Ltd Company Summary
Table 47. Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Product Offerings
Table 48. Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Beijing Minhai Biotechnology Co Ltd Key News & Latest Developments
Table 50. Biological E Ltd Company Summary
Table 51. Biological E Ltd Neisseria meningitidis Infections Drug Product Offerings
Table 52. Biological E Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Biological E Ltd Key News & Latest Developments
Table 54. China National Pharmaceutical Group Corp Company Summary
Table 55. China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Product Offerings
Table 56. China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. China National Pharmaceutical Group Corp Key News & Latest Developments
Table 58. GlaxoSmithKline Plc Company Summary
Table 59. GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Product Offerings
Table 60. GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. GlaxoSmithKline Plc Key News & Latest Developments
Table 62. Griffith University Company Summary
Table 63. Griffith University Neisseria meningitidis Infections Drug Product Offerings
Table 64. Griffith University Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Griffith University Key News & Latest Developments
Table 66. ImmunoBiology Ltd Company Summary
Table 67. ImmunoBiology Ltd Neisseria meningitidis Infections Drug Product Offerings
Table 68. ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. ImmunoBiology Ltd Key News & Latest Developments
Table 70. JN-International Medical Corp Company Summary
Table 71. JN-International Medical Corp Neisseria meningitidis Infections Drug Product Offerings
Table 72. JN-International Medical Corp Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. JN-International Medical Corp Key News & Latest Developments
Table 74. MGB Biopharma Ltd Company Summary
Table 75. MGB Biopharma Ltd Neisseria meningitidis Infections Drug Product Offerings
Table 76. MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. MGB Biopharma Ltd Key News & Latest Developments
Table 78. Panacea Biotec Ltd Company Summary
Table 79. Panacea Biotec Ltd Neisseria meningitidis Infections Drug Product Offerings
Table 80. Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. Panacea Biotec Ltd Key News & Latest Developments
Table 82. Pfizer Inc Company Summary
Table 83. Pfizer Inc Neisseria meningitidis Infections Drug Product Offerings
Table 84. Pfizer Inc Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. Pfizer Inc Key News & Latest Developments
Table 86. Sanofi Pasteur SA Company Summary
Table 87. Sanofi Pasteur SA Neisseria meningitidis Infections Drug Product Offerings
Table 88. Sanofi Pasteur SA Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 89. Sanofi Pasteur SA Key News & Latest Developments
Table 90. Serum Institute of India Ltd Company Summary
Table 91. Serum Institute of India Ltd Neisseria meningitidis Infections Drug Product Offerings
Table 92. Serum Institute of India Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 93. Serum Institute of India Ltd Key News & Latest Developments
Table 94. Wellstat Vaccines LLC Company Summary
Table 95. Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Product Offerings
Table 96. Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 97. Wellstat Vaccines LLC Key News & Latest Developments
Table 98. Neisseria meningitidis Infections Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 99. Global Neisseria meningitidis Infections Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Neisseria meningitidis Infections Drug Production by Region, 2018-2023 (K Pcs)
Table 101. Global Neisseria meningitidis Infections Drug Production by Region, 2024-2030 (K Pcs)
Table 102. Neisseria meningitidis Infections Drug Market Opportunities & Trends in Global Market
Table 103. Neisseria meningitidis Infections Drug Market Drivers in Global Market
Table 104. Neisseria meningitidis Infections Drug Market Restraints in Global Market
Table 105. Neisseria meningitidis Infections Drug Raw Materials
Table 106. Neisseria meningitidis Infections Drug Raw Materials Suppliers in Global Market
Table 107. Typical Neisseria meningitidis Infections Drug Downstream
Table 108. Neisseria meningitidis Infections Drug Downstream Clients in Global Market
Table 109. Neisseria meningitidis Infections Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Neisseria meningitidis Infections Drug Segment by Type in 2022
Figure 2. Neisseria meningitidis Infections Drug Segment by Application in 2022
Figure 3. Global Neisseria meningitidis Infections Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Neisseria meningitidis Infections Drug Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Neisseria meningitidis Infections Drug Revenue, 2018-2030 (US$, Mn)
Figure 7. Neisseria meningitidis Infections Drug Sales in Global Market: 2018-2030 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Neisseria meningitidis Infections Drug Revenue in 2022
Figure 9. By Type - Global Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Neisseria meningitidis Infections Drug Revenue Market Share, 2018-2030
Figure 11. By Type - Global Neisseria meningitidis Infections Drug Sales Market Share, 2018-2030
Figure 12. By Type - Global Neisseria meningitidis Infections Drug Price (USD/Pcs), 2018-2030
Figure 13. By Application - Global Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Neisseria meningitidis Infections Drug Revenue Market Share, 2018-2030
Figure 15. By Application - Global Neisseria meningitidis Infections Drug Sales Market Share, 2018-2030
Figure 16. By Application - Global Neisseria meningitidis Infections Drug Price (USD/Pcs), 2018-2030
Figure 17. By Region - Global Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Neisseria meningitidis Infections Drug Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Neisseria meningitidis Infections Drug Revenue Market Share, 2018-2030
Figure 20. By Region - Global Neisseria meningitidis Infections Drug Sales Market Share, 2018-2030
Figure 21. By Country - North America Neisseria meningitidis Infections Drug Revenue Market Share, 2018-2030
Figure 22. By Country - North America Neisseria meningitidis Infections Drug Sales Market Share, 2018-2030
Figure 23. US Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Neisseria meningitidis Infections Drug Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Neisseria meningitidis Infections Drug Sales Market Share, 2018-2030
Figure 28. Germany Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2030
Figure 29. France Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Neisseria meningitidis Infections Drug Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Neisseria meningitidis Infections Drug Sales Market Share, 2018-2030
Figure 37. China Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2030
Figure 41. India Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Neisseria meningitidis Infections Drug Revenue Market Share, 2018-2030
Figure 43. By Country - South America Neisseria meningitidis Infections Drug Sales Market Share, 2018-2030
Figure 44. Brazil Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Neisseria meningitidis Infections Drug Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Neisseria meningitidis Infections Drug Sales Market Share, 2018-2030
Figure 48. Turkey Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Neisseria meningitidis Infections Drug Revenue, (US$, Mn), 2018-2030
Figure 52. Global Neisseria meningitidis Infections Drug Production Capacity (K Pcs), 2018-2030
Figure 53. The Percentage of Production Neisseria meningitidis Infections Drug by Region, 2022 VS 2030
Figure 54. Neisseria meningitidis Infections Drug Industry Value Chain
Figure 55. Marketing Channels
